Furthermore, relative to CD19-CAR-T cells and control T cells treatment, CD70-CAR-T cells significantly prolonged the survival of mice bearing AML cells and effectively inhibited tumor growth. This evidence concerns the gene CD19 and acute myeloid leukemia.